(Q39514657)

12 September 2017

title

A prospective, double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department (English)

1 reference

12 September 2017

1 reference

1 reference

Tek DS

1

1 reference

12 September 2017

McClellan DS

2

1 reference

12 September 2017

Olshaker JS

3

1 reference

12 September 2017

Allen CL

4

1 reference

12 September 2017

Arthur DC

5

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 October 1990

1 reference

Annals of Emergency Medicine

12 September 2017

published in

1 reference

12 September 2017

volume

19

1 reference

12 September 2017

issue

10

1 reference

12 September 2017

page(s)

1083-1087

1 reference

Non-traumatic headache in the emergency department

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

Comparative efficacy of chlorpromazine and meperidine with dimenhydrinate in migraine headache

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

Dihydroergotamine nasal spray during migraine attacks. A double-blind crossover study with placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

Repetitive intravenous dihydroergotamine as therapy for intractable migraine.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

A controlled study of dihydroergotamine in the treatment of acute migraine headache

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

Use of Ergot Preparations in Acute Migraine Attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

Ergotamine induced headaches in migrainous patients

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

Endorphins, Opiate Receptors and Migraine Headache

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

Hypothesis: migraine, a central biochemical dysnociception

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

The effectiveness of nalbuphine and hydroxyzine for the emergency treatment of severe headache

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

Aspirin treatment of migraine attacks: plasma drug level data

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

Tolfenamic acid and caffeine: a useful combination in migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

Effects of migraine attack and metoclopramide on the absorption of tolfenamic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

Effervescent Metoclopramide and Aspirin (Migravess) Versus Effervescent Aspirin or Placebo for Migraine Attacks: A Double-Blind Study

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

Tolfenamic acid, metoclopramide, caffeine and their combinations in the treatment of migraine attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

Treatment of the acute migraine attack--current status.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

Parenteral chlorpromazine treatment of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

Menstrual migraine: a double-blind trial of percutaneous estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

Effectiveness of salmon calcitonin nasal spray preparation in migraine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

Flunarizine i.v. in the acute treatment of the migraine attack. A double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

Migraine--treatment of acute attack.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

A double blind study of metoclopramide in the treatment of migraine attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

Endorphin levels in headache syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

Endogenous Opioids in Cerebrospinal Fluid and Blood in Idiopathic Headache Sufferers

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

Primary Headaches: Reduced Circulating β-Lipotropin and β-Endorphin Levels with Impaired Reactivity to Acupuncture

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

Naloxone Effectiveness on Spontaneous and Induced Perceptive Disorders in Migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

Naloxone antagonism of stress-induced augmentation of frontal cortex dopamine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2981508-2

7 January 2021

10.1016/S0196-0644(05)81508-2

Identifiers

DOI

1 reference

12 September 2017

1 reference